Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants.

Blood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants. J Perinatol (2013) 0.81

Nasopharyngeal carriage of Streptococcus pneumoniae in very low-birth-weight infants after administration of heptavalent pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med (2010) 0.78

Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants. Pediatr Infect Dis J (2013) 0.75

Vaccine schedule compliance among very low birth weight infants in Lima, Peru. Vaccine (2014) 0.75

A United States national reference for fetal growth. Obstet Gynecol (1996) 13.21

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J (2000) 11.94

Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 4.53

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics (1998) 3.13

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine (2003) 2.87

Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin Vaccine Immunol (2006) 2.20

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J (1999) 1.84

Severe apnoeas following immunisation in premature infants. Arch Dis Child Fetal Neonatal Ed (1999) 1.54

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis (1996) 1.52

Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease. Pediatrics (2004) 1.52

Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics (1995) 1.36

Recommended childhood and adolescent immunization schedule--United States, January-June 2004. MMWR Morb Mortal Wkly Rep (2004) 1.30

Incidence of apnoea and bradycardia in preterm infants following DTPw and Hib immunization: a prospective study. J Paediatr Child Health (1997) 1.29

Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis (1994) 1.25

Apnea after immunization of preterm infants. J Pediatr (1997) 1.21

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J (2002) 1.20

Incidence of apnoea and bradycardia in preterm infants following triple antigen immunization. J Paediatr Child Health (1994) 1.17

Response of preterm infants to hepatitis B vaccine. J Pediatr (1992) 1.13

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine (2005) 1.07

Antibody response to oral polio vaccine in premature infants. J Pediatr (1983) 1.06

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine (2006) 1.02

Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J Pediatr (1993) 1.02

Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics (1995) 1.01

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics (1999) 0.95

Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed (1999) 0.95

Interleukin-6, C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants. Pediatrics (1998) 0.89

Three-year follow-up of vaccine response in extremely preterm infants. Pediatrics (1998) 0.86

Tolerance of initial diphtheria-tetanus-pertussis immunization in preterm infants. J Perinatol (1996) 0.78

Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2005) 13.96

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics (2002) 9.87

Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15

Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics (2005) 8.99

Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA (2004) 7.45

Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med (2010) 6.86

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med (2013) 6.70

Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol (2007) 6.68

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89

Early CPAP versus surfactant in extremely preterm infants. N Engl J Med (2010) 5.23

Intensive care for extreme prematurity--moving beyond gestational age. N Engl J Med (2008) 5.10

Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med (2015) 4.90

Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med (2002) 4.62

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics (2005) 4.49

Necrotising enterocolitis. Lancet (2006) 3.94

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics (2011) 3.84

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics (2006) 3.78

Linear motif atlas for phosphorylation-dependent signaling. Sci Signal (2008) 3.77

Oronasopharyngeal suction versus wiping of the mouth and nose at birth: a randomised equivalency trial. Lancet (2013) 3.73

Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med (2012) 3.37

Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr (2011) 3.36

Newborn oto-acoustic emission hearing screening tests: preliminary evidence for a marker of susceptibility to SIDS. Early Hum Dev (2007) 3.30

Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents. Pediatrics (2005) 3.29

Brain damage in preterm newborns and maternal medication: the ELGAN Study. Am J Obstet Gynecol (2012) 3.28

Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev (2005) 3.20

Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics (2006) 3.16

Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics (2006) 3.13

15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol (2005) 3.13

The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics (2002) 3.07

Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9. PLoS Genet (2007) 3.07

Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics (2005) 3.06

Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics (2009) 3.05

BLAP75/RMI1 promotes the BLM-dependent dissolution of homologous recombination intermediates. Proc Natl Acad Sci U S A (2006) 3.00

Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics (2006) 2.98

Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J (2005) 2.85

Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med (2005) 2.81

A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates. N Engl J Med (2015) 2.73

Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics (2006) 2.71

The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics (2005) 2.65

Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics (2005) 2.60

BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J (2005) 2.60

Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med (2015) 2.59